Delivery Order SPE2DB24D9315-SPE2DB25FFWLK
Award Date 7/28/25
Potential Completion Date 7/29/25
Potential Value $4.2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- On August 22, 2025, the Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $23,366.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, numbered 4569186045, calls for the supply of 60 tablets of Xtandi 80 mg, an oncology medication used in the treatment of prostate cancer. This award represents a single delivery order issued under DMS Pharmaceutical Group's existing...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,868.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on September 4, 2025. This firm fixed-price delivery order covers the supply of Xtandi 40 mg capsules (120-count units), an oncology medication used in prostate cancer treatment. The contract carries no set-aside designation and is scheduled for ultimate completion by September 5, 2025, with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on August 14, 2025. This firm fixed-price delivery order covers the supply of Xtandi 80 mg tablets (60-count units), an oncology medication used in prostate cancer treatment. The award carries no set-aside designation and is scheduled for completion by August 15, 2025, with performance taking...
- On June 2, 2025, the Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. The delivery order calls for the supply of Xtandi 40 mg tablets (120-count units), an oncology medication used in prostate cancer treatment. This award was issued on a firm fixed-price basis with an ultimate completion date...
- On August 7, 2025, the Defense Logistics Agency awarded a firm fixed-price delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, identified as 4569023499, is for 60 tablets of Xtandi 80 mg, an oncology medication. This award was issued without a set-aside designation and carries an ultimate completion date of August 8, 2025. The order represents a single delivery under DMS...
- On September 17, 2025, the Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order covers 60 tablets of Xtandi 80 mg, an oncology medication used in prostate cancer treatment. This award was issued without set-aside designation, reflecting DMS Pharmaceutical Group's competitive position in federal pharmaceutical...
- On August 1, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $4,311.35 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, issued under contract number 4568977608, calls for the supply of Xtandi 40 mg capsules in quantities of 120 units, with an ultimate completion date of August 4, 2025. This award was made on a firm fixed-price basis with no set-aside designation, leveraging...
- On August 11, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $8,622.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order covers 120 capsules of Xtandi 40 mg, an oncology treatment medication, under a firm fixed-price contract with an ultimate completion date of August 12, 2025. This award was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,169.59 by the Defense Logistics Agency (DLA) on July 22, 2025. The contract, which carries no set-aside designation, calls for the delivery of 60 tablets of Xtandi 80 mg, an oncology medication used in cancer treatment. This delivery order represents one of many pharmaceutical supply orders issued under DMS...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,622.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count units). This firm fixed-price delivery order, issued on September 19, 2025, with an ultimate completion date of September 22, 2025, was awarded without set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open...